Milestone Pharmaceuticals (MIST) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Milestone Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $1.2M of MIST stock on the open market.
Get emailed when insiders cluster-buy stocks like MIST
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
MIST insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $82K | 1 |
| Q1 2026 | — | 0 | $257K | 7 |
| Q4 2025 | — | 0 | $837K | 5 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Milestone Pharmaceuticals Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $1.2M. 3 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 20SEC | Joseph OlivetoCEO, President | Sell Plan | 36,500446,244 held (−8%) | $2.26 | $82K | -66.2% | — |
| Jan 28SEC | Joseph OlivetoCEO, President | Sell | 133,054450,667 held (−23%) | $2.32 | $309K | -67.0% | — |
| Jan 28SEC | David BharuchaChief Medical Officer | Sell | 58,007105,326 held (−36%) | $2.32 | $135K | -67.0% | — |
| Jan 28SEC | Amit HasijaCFO | Sell | 58,00791,993 held (−39%) | $2.32 | $135K | -67.0% | — |
| Jan 28SEC | Jeffrey Edward NelsonCOO | Sell | 58,00741,993 held (−58%) | $2.32 | $135K | -67.0% | — |
| Jan 28SEC | Lorenz MullerChief Commercial Officer | Sell | 53,566196,486 held (−21%) | $2.32 | $124K | -67.0% | — |
| Jan 28SEC | Joseph OlivetoCEO, President | Sell | 34,523482,744 held (−7%) | $1.93 | $67K | -60.4% | — |
| Jan 28SEC | David BharuchaChief Medical Officer | Sell | 12,245113,181 held (−10%) | $1.93 | $24K | -60.4% | — |
| Jan 28SEC | Amit HasijaCFO | Sell | 12,24599,848 held (−11%) | $1.93 | $24K | -60.4% | — |
| Jan 28SEC | Jeffrey Edward NelsonCOO | Sell | 12,24549,848 held (−20%) | $1.93 | $24K | -60.4% | — |
| Jan 28SEC | Lorenz MullerChief Commercial Officer | Sell | 11,180205,406 held (−5%) | $1.93 | $22K | -60.4% | — |
| Jan 9SEC | Joseph OlivetoCEO, President | Sell Plan | 43,000303,721 held (−12%) | $2.25 | $97K | -66.0% | — |
| Jan 9SEC | Joseph OlivetoCEO, President | Sell Plan | 500346,721 held (−0%) | $2.25 | $1K | -66.0% | — |
Insiders at Milestone Pharmaceuticals Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Joseph OlivetoCEO, President | — | $556K | Apr 20, 2026 | — |
| David BharuchaChief Medical Officer | — | $158K | Jan 28, 2026 | — |
| Amit HasijaCFO | — | $158K | Jan 28, 2026 | — |
| Jeffrey Edward NelsonCOO | — | $158K | Jan 28, 2026 | — |
| Lorenz MullerChief Commercial Officer | — | $146K | Jan 28, 2026 | — |
MIST stock: common questions
Are Milestone Pharmaceuticals Inc. insiders buying MIST stock?
In the past 12 months, 0 insiders reported open-market purchases of MIST worth $0.
Are Milestone Pharmaceuticals Inc. insiders selling MIST stock?
5 insiders reported sales worth $1.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is MIST's 52-week range?
Over the past year MIST has traded between $0.71 and $2.95. It last closed at $0.77 on Oct 9, 2026.